Patent · US Active

Compounds and compositions as protein kinase inhibitors

US8242260B2 · kind B2 · utility

9Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2010
Grant dateAug 14, 2012
Priority date—
Expiry dateAug 24, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds of Formula I or II:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.